Medicare Part D Subsidy Expiration Raises Enrollee Concerns

Why it matters locally: West Virginia, with its significant elderly population and higher rates of chronic conditions, may see a disproportionate impact on its Medicare Part D enrollees as they face potential increases in prescription drug costs.

WASHINGTON – The Trump administration's decision to discontinue a specific subsidy for Medicare Part D enrollees is generating questions among beneficiaries regarding their future drug coverage costs. Enrollees are expressing concerns about potential increases in the amounts they will pay for their medications. This change stems from an administrative action affecting the Medicare Part D program. Individuals enrolled in this prescription drug coverage plan are now evaluating the financial implications of the subsidy's expiration. The removal of the subsidy directly impacts the structure of their out-of-pocket expenses for covered medications.